Used in research as a peroxisome proliferator-activated receptor gamma (PPARγ) agonist, this compound is studied for its potential in regulating glucose metabolism and improving insulin sensitivity. It serves as a tool compound in developing therapies for type 2 diabetes and metabolic disorders. Its structure allows interaction with nuclear receptors involved in adipogenesis and lipid metabolism, making it valuable in pharmacological studies targeting metabolic syndrome. Additionally, it has been explored for anti-inflammatory and anticancer properties due to PPARγ’s role in cell differentiation and apoptosis.